http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S646216-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c3be79bbfe3d011d55eeef3581292e6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-465
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
filingDate 1988-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_613aeb81740c3fe2686c234c1d9ee05d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bfa880a9bde4727ebb14c8cf5290d05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee92d4fed91bcb898b360fb6f6eb2153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86c2b7d62410e8c9ac2787d9f93e37aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3382f089e5eda7d0c2e7af59342e685b
publicationDate 1989-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S646216-A
titleOfInvention Therapy for abstinence symptom related to no smoking and medicine therefor
abstract PURPOSE: To obtain a preparation suitable for a treatment of abstinence symptoms related to an event of smoking cessation and percutaneously administered once daily by uniformly distributing nicotine in a solid, a semisolid or a thixotropic medium arranged so as to make a contact with a skin. CONSTITUTION: This preparation for a treatment of abstinence symptoms related to an event of smoking cessation, is obtained by dissolving a solidifying agent or a gel forming agent (e.g.; plant extracts, rubbers, synthetic or natural polysaccharides, polypeptides, alginic acid salts and synthetic polymers) into a solvent such as water, an alcohol, glycerol and ethylene glycol or their mixtures, adding a prescribed amount of nicotine and mixing or adding the obtained mixture. The amount of administered nicotine is preferably an amount sufficient to obtain 2-100ng/ml, especially 5-30ng/ml plasma nicotine concentration for 1-24hr, and also the amount of administered nicotine is preferably decreased gradually over a certain period of time so as to reduce the dependency to nicotine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013523090-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013075924-A
priorityDate 1987-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61251619-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410

Total number of triples: 44.